STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

As the Minister said, the pharmaceutical industry, through research and innovation, becomes more competitive, more ...

In a significant financial move in the pharmaceutical industry, Edwards Life Sciences has sold its Critical Care division to Becton Dickinson (BD) for $4,200 million. The transaction, legally executed ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

Morocco is one of the key buyers of Russian pharmaceutical products, along with Algeria, Uganda, the Congo, and Nigeria with last year’s value of Russian pharmaceutical exports to Africa reaching ...

With increasing pharmaceutical production and a growing focus on patient safety, the demand for specialized and customizable ...

a leading industry group. That’s 25% larger than it was in 2019, making it bigger than the sports and pharmaceutical industries. “Growth was even stronger than we predicted,” says Katherine ...

Despite the relatively low profile, Tianjin Pharmaceutical's improved earnings have earned recognition from investors ...

The Marin County developer of treatments for rare diseases noted that its treatment for a form of rickets has been driving ...

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.